Inflammatory and Hematological Biomarkers as Indicators of Psoriatic Arthritis in Patients Attending Dermatology Clinic
DOI:
https://doi.org/10.54133/ajms.v10i2.2939Keywords:
CASPAR criteria, C-Reactive protein, DAPSA scores , Erythrocyte sedimentation rate, Psoriatic arthritisAbstract
Background: Psoriatic arthritis (PsA), a heterogeneous inflammatory arthropathy where inflammatory biomarkers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) show normal levels in over half of cases in spite of having clinically active disease. Hemoglobin, a readily available parameter, remains a largely underexplored surrogate of systemic inflammatory burden in PsA. Methods: Consecutive sampling was used to enroll 132 PsA patients (CASPAR criteria) attending the Dermatology Outpatient Clinics of Al Yarmouk Hospital via a cross-sectional study. Disease activity was stratified based on the Disease Activity Index for PsA (DAPSA) into low (≤13), moderate (14–27), and high (>27). Demographic and lab tests, hematological and inflammatory (full blood count, CRP, and ESR), were measured for all. Anemia was defined by WHO sex-specific thresholds. Results: mean age of enrolled cases (46.3±14.3 years; 61.4% female). High disease activity was reported in 58.4% of patients. All hematological and inflammatory indicators show significant differences across DAPSA strata. Hemoglobin fell negatively with rising disease activity (12.80±1.95g/dL in moderate vs. 11.30±1.6g/dL in high activity). Anemia (56.1%) was independently associated with higher DAPSA scores (51.9±39.2 vs. 35.4±40.2; p<0.001), increased acute-phase reactants, and female gender. Psoriasis duration correlated negatively with hemoglobin (r= −0.28, p=0.001) but not with CRP or ESR. Conclusions: Hemoglobin is a cost-free, available, and clinically meaningful biomarker that matches DAPSA-defined disease activity in PsA more reliably than CRP or ESR in real-world practice.
Downloads
References
Kang Z, Zhang X, Du Y, Dai SM. Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: a comprehensive systematic analysis and modelling study. J Autoimmun. 2024;145:103202. doi: 10.1016/j.jaut.2024.103202. DOI: https://doi.org/10.1016/j.jaut.2024.103202
Novelli L, Lubrano E, Venerito V, Perrotta FM, Marando F, Curradi G, et al. Extra-articular manifestations and comorbidities in psoriatic disease: a journey into the immunologic crosstalk. Front Med (Lausanne). 2021;8:737079. doi: 10.3389/fmed.2021.737079. DOI: https://doi.org/10.3389/fmed.2021.737079
Lembke S, Macfarlane GJ, Jones GT. The worldwide prevalence of psoriatic arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2024;63(12):3211-3220. doi: 10.1093/rheumatology/keae198. DOI: https://doi.org/10.1093/rheumatology/keae198
Atzeni F, Gerratana E, Masala IF, Bongiovanni S, Sarzi-Puttini P, Rodríguez-Carrio J. Psoriatic arthritis and metabolic syndrome: is there a role for disease-modifying anti-rheumatic drugs? Front Med (Lausanne). 2021;8:735150. doi: 10.3389/fmed.2021.735150. DOI: https://doi.org/10.3389/fmed.2021.735150
Proft F, Schally J, Brandt HC, Brandt-Juergens J, Burmester GR, Haibel H, et al. Evaluation of the disease activity index for psoriatic arthritis (DAPSA) with a quick quantitative C-reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study. RMD Open. 2022;8(2):e002626. doi: 10.1136/rmdopen-2022-002626. DOI: https://doi.org/10.1136/rmdopen-2022-002626
Houttekiet C, de Vlam K, Neerinckx B, Lories R. Systematic review of the use of CRP in clinical trials for psoriatic arthritis: a concern for clinical practice? RMD Open. 2022;8(1):e001847. doi: 10.1136/rmdopen-2021-001756. DOI: https://doi.org/10.1136/rmdopen-2021-001756
Queiro R, Alonso S, Alperi M. Reassessing traditional inflammatory biomarkers in spondyloarthritis: time for a paradigm shift? Expert Rev Clin Immunol. 2025;21(10):1315-1319. doi: 10.1080/1744666X.2025.2568890. DOI: https://doi.org/10.1080/1744666X.2025.2568890
Pogorzelska K, Krętowska A, Krawczuk-Rybak M, Sawicka-Żukowska M. Characteristics of platelet indices and their prognostic significance in selected medical conditions: a systematic review. Adv Med Sci. 2020;65(2):310-315. doi: 10.1016/j.advms.2020.05.002. DOI: https://doi.org/10.1016/j.advms.2020.05.002
Nori W, Roomi AB, Akram W. Platelet indices as predictors of fetal growth restriction in pre-eclamptic women. Rev Latinoam Hypertens. 2020;15(4):280-285.
Lee SH, Kim M, Han KD, Lee JH. Low hemoglobin levels and an increased risk of psoriasis in patients with chronic kidney disease. Sci Rep. 2021;11:14741. doi: 10.1038/s41598-021-94116-2. DOI: https://doi.org/10.1038/s41598-021-94165-w
Bedaiwi M, Al-Homood IA, El-Garf A, Uthman I, Sunna N, Nassier R, et al. Disease burden and treatment challenges of psoriatic arthritis in Africa and the Middle East. Rheumatol Int. 2019;39(8):1321-1329. doi: 10.1007/s00296-019-04319-3. DOI: https://doi.org/10.1007/s00296-019-04319-3
Tillett W, Costa L, Jadon D, Wallis D, Cavill C, McHugh JE, et al. The Classification for psoriatic arthritis (CASPAR) criteria—a retrospective feasibility, sensitivity, and specificity study. J Rheumatol. 2012;39(1):154-156. doi: 10.3899/jrheum.110845. DOI: https://doi.org/10.3899/jrheum.110845
Schoels MM, Aletaha D, Alasti F, Smolen JS. Disease activity in psoriatic arthritis: defining remission and treatment success using the DAPSA score. Ann Rheum Dis. 2016;75(5):811-818. doi: 10.1136/annrheumdis-2015-207507. DOI: https://doi.org/10.1136/annrheumdis-2015-207507
Robinson A, Kardos M, Kimball AB. Physician global assessment (PGA) and psoriasis area and severity index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate-to-severe plaque psoriasis. J Am Acad Dermatol. 2012;66(3):369-375. doi: 10.1016/j.jaad.2011.01.022. DOI: https://doi.org/10.1016/j.jaad.2011.01.022
Hackett S, Ogdie A, Coates LC. Psoriatic arthritis: prospects for the future. Ther Adv Musculoskelet Dis. 2022;14:1759720X221086710. doi: 10.1177/1759720X221086710. DOI: https://doi.org/10.1177/1759720X221086710
Wirth T, Balandraud N, Boyer L, Lafforgue P, Pham T. Biomarkers in psoriatic arthritis: a meta-analysis and systematic review. Front Immunol. 2022;13:1054539. doi: 10.3389/fimmu.2022.1054539. DOI: https://doi.org/10.3389/fimmu.2022.1054539
Lee BW, Moon SJ. Inflammatory cytokines in psoriatic arthritis: understanding pathogenesis and implications for treatment. Int J Mol Sci. 2023;24(14):11662. doi: 10.3390/ijms241411662. DOI: https://doi.org/10.3390/ijms241411662
Lazarut-Nistor A, Slevin M. Beyond the biomarker: monomeric CRP as a driver of multisystem pathology in rheumatoid arthritis. Int J Mol Sci. 2025;26(17):8227. doi: 10.3390/ijms26178227. DOI: https://doi.org/10.3390/ijms26178227
Skougaard M, Ditlev SB, Søndergaard MF, Kristensen LE. Cytokine signatures in psoriatic arthritis patients indicate different phenotypic traits comparing responders and non-responders of IL-17A and TNF-α inhibitors. Int J Mol Sci. 2023;24(7):6343. doi: 10.3390/ijms24076343. DOI: https://doi.org/10.3390/ijms24076343
Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40-50. doi: 10.1182/blood-2018-06-856500. DOI: https://doi.org/10.1182/blood-2018-06-856500
Lanser L, Fuchs D, Kurz K, Weiss G. Physiology and inflammation-driven pathophysiology of iron homeostasis—mechanistic insights into anemia of inflammation and its treatment. Nutrients. 2021;13(11):3732. doi: 10.3390/nu13113732. DOI: https://doi.org/10.3390/nu13113732
Corrado A, Di Bello V, d’Onofrio F, Maruotti N, Cantatore FP. Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis. Int J Immunopathol Pharmacol. 2017;30(3):302-307. doi: 10.1177/0394632017714695. DOI: https://doi.org/10.1177/0394632017714695
Su F, Cao L, Ren X, Hu J, Tavengana G, Wu H, et al. Age and sex trend differences in hemoglobin levels in China: a cross-sectional study. BMC Endocr Disord. 2023;23(1):8. doi: 10.1186/s12902-022-01218-w. DOI: https://doi.org/10.1186/s12902-022-01218-w
Kreiner FF, Kraaijenhof JM, von Herrath M, Hovingh GK, von Scholten BJ. Interleukin-6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives. Expert Rev Clin Immunol. 2022;18(4):377-389. doi: 10.1080/1744666X.2022.2045952. DOI: https://doi.org/10.1080/1744666X.2022.2045952
Micheroli R, Kissling S, Bürki K, Möller B, Finckh A, Nissen MJ, et al. Anemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry. Clin Rheumatol. 2023;42(9):2377-2385. doi: 10.1007/s10067-023-06662-0. DOI: https://doi.org/10.1007/s10067-023-06662-0
Shen J, Shang Q, Li EK, Leung YY, Kun EW, Kwok LW, et al. Cumulative inflammatory burden is independently associated with increased arterial stiffness in patients with psoriatic arthritis: a prospective study. Arthritis Res Ther. 2015;17:75. doi: 10.1186/s13075-015-0570-0. DOI: https://doi.org/10.1186/s13075-015-0570-0
Shadick N, Hagino O, Praestgaard A, Fiore S, Weinblatt M, Burmester G. Association of hemoglobin levels with radiographic progression in patients with rheumatoid arthritis: an analysis from the BRASS registry. Arthritis Res Ther. 2023;25(1):88. doi: 10.1186/s13075-023-03068-w. DOI: https://doi.org/10.1186/s13075-023-03068-w
Rubbert-Roth A, Furst DE, Fiore S, Praestgaard A, Bykerk V, Bingham CO, et al. Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab. Arthritis Res Ther. 2022;24(1):207. doi: 10.1186/s13075-022-02891-x. DOI: https://doi.org/10.1186/s13075-022-02891-x
Chandran V, Liao W, de Vlam K. Biomarkers in psoriasis and psoriatic arthritis: where are we now? J Rheumatol. 2024;51(Suppl 2):74-76. doi: 10.3899/jrheum.2024-0260. DOI: https://doi.org/10.3899/jrheum.2024-0260
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Published by Al-Rafidain University College. This is an open access journal issued under the CC BY-NC-SA 4.0 license (https://creativecommons.org/licenses/by-nc-sa/4.0/).
